COMUNICATO STAMPA
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
MolMed - Wikipedia
Relazione sulla remunerazione Molecular Medicine S.p.A.
Il Consiglio di Amministrazione di MolMed convoca l'Assemblea degli Azionisti
MolMed now part of AGC Biologics | Iterate.ai
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed sigla accordo Boston Children's Hospital
Meeting agenda | molmed
Will MolMed soon have its first Cell therapy on the Market?
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
MolMed now part of AGC Biologics | LinkedIn
Will MolMed soon have its first Cell therapy on the Market?
Investire nella Borsa italiana. Analisi fondamentale del Healthcare – Vera Finanza
COMUNICATO STAMPA
MolMed: Contact Details and Business Profile
MolMed now part of AGC Biologics | Iterate.ai
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
Azioni Molecular Medicine in Borsa | Quotazione F: 4HW - Investing.com
Piazza Affari: con l'OPA MolMed offre (ancora) rendimento del 10% | Investire.biz
OFFERTE PUBBLICHE DI ACQUISTO
MolMed 06
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
Piazza Affari: Molmed scende verso 0,4305 Euro
